Palisade Bio, Inc. Share Price
PALIPalisade Bio, Inc. Stock Performance
Open $1.90 | Prev. Close $2.05 | Circuit Range N/A |
Day Range $1.88 - $2.07 | Year Range $0.53 - $3.30 | Volume 2,01,418 |
Average Traded $1.99 |
Palisade Bio, Inc. Share Price Chart
About Palisade Bio, Inc.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.
Palisade Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.90 | $2.04 | +0.00% |
12-Nov-25 | $1.90 | $2.04 | +12.43% |
11-Nov-25 | $1.77 | $1.81 | +2.26% |
10-Nov-25 | $1.71 | $1.77 | +5.04% |
07-Nov-25 | $1.60 | $1.69 | +1.81% |
06-Nov-25 | $1.75 | $1.66 | -1.19% |
05-Nov-25 | $1.82 | $1.68 | -8.72% |
FAQs on Palisade Bio, Inc. Share Price
Can I buy Palisade Bio, Inc. shares in India?
What is the share price of Palisade Bio, Inc.?
What is the 5 year returns of Palisade Bio, Inc.?
What are the high & low stock price of Palisade Bio, Inc. today?
What is the 52-week high and low of Palisade Bio, Inc. stock?